Hepalink takes 10% stake in ProMetic; companies sign R&D collaboration
ProMetic Life Sciences Inc. (blood purification processes and drug candidates for various diseases) and heparin manufacturer Shenzhen Hepalink Pharmaceutical Co. Ltd. have established a joint R&D collaboration involving ProMetic's protein technologies. In addition, Hepalink is taking a 10.02% stake in ProMetic for $Cdn10mm ($9.6mm).
- Large Molecule
- Synthesis Technologies, Production Processes
- Includes Equity
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com